Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ARS Pharmaceuticals (SPRY) Change in Inventory (2024 - 2025)

ARS Pharmaceuticals' Change in Inventory history spans 2 years, with the latest figure at $9.7 million for Q4 2025.

  • For Q4 2025, Change in Inventory rose 68.64% year-over-year to $9.7 million; the TTM value through Dec 2025 reached $22.0 million, up 269.82%, while the annual FY2025 figure was $22.0 million, 269.82% up from the prior year.
  • Change in Inventory for Q4 2025 was $9.7 million at ARS Pharmaceuticals, up from -$963000.0 in the prior quarter.
  • Across five years, Change in Inventory topped out at $9.7 million in Q4 2025 and bottomed at -$963000.0 in Q3 2025.